St. Petersburg state budgetary institution of health care " City hospital № 26" Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2018
NCT03638830
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

St. Petersburg state budgetary institution of health care " City hospital № 26"

Active Ingredients

Drugs in Phase 2 Trials (2)

cefepime (maxipeme) (1 trial)

fluticasone (cutivate) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Infections (Phase 2)

Pseudomonas Infections (Phase 2)

Urinary Tract Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2